Researchers have spent more than three decades developing and studying miniature biosensors that can identify single molecules.
In five to 10 years, when such devices may become a staple in doctors’ offices, they could detect molecular markers for cancer and other diseases and assess the effectiveness of drug treatment to fight those illnesses.
To help make that happen and to boost the accuracy and speed of these measurements, scientists must find ways to better understand how molecules interact with these sensors. [Read more…] about NIST study suggests how to build a better ‘nanopore’ biosensor
Related Posts
- 37The death of neurons specialised in the synthesis of dopamine, one of the brain's main neurotransmissors, deteriorates the motor and cognitive capacities of those with Parkinson's disease. The loss of these neurons is related to alpha-synuclein aggregation. Recent studies show that oligomers, the initial aggregates of this protein, are the…